Ping W Fisher, MD
Internal Medicine · Menlo Park
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
- Since medical school
- 14 years
- University of California, Davis School of Medicine, 2012
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fisher’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A126598 · Current
Licensed to practise in California · since 2013 · expires 2027-03-31 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$124,973
Medicare paid this office $124,973 for 304 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 226 | $35,678 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 115 | $17,604 | $153 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 44 | $12,732 | $289 |
| Long return visit (40+ min) | 46 | $10,991 | $157 |
| Short return visit (20+ min) | 87 | $6,252 | $61 |
See all 14 services
| Return visit (30+ min) | 226 | $35,678 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 115 | $17,604 | $153 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 44 | $12,732 | $289 |
| Long return visit (40+ min) | 46 | $10,991 | $157 |
| Short return visit (20+ min) | 87 | $6,252 | $61 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 192 | $4,191 | $14 |
| Sarscv2 vac 30mcg trs-suc im | 25 | $3,358 | $134 |
| Sarscov2 vac 50 mcg/0.5ml im | 20 | $3,034 | $144 |
| Admn sarscov2 vacc 1 dose | 44 | $2,373 | $52 |
| Administration of pneumococcal vaccine | 44 | $1,682 | $38 |
| Influenza vaccine split virus, preservative free | 13 | $1,054 | $81 |
| Administration of influenza virus vaccine | 13 | $497 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $167 | $11 |
| Automated urinalysis test | 17 | $37 | $2 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
304 Original Medicare patients in 2024. Average age 76 · Women 83% · Health risk score 0.77. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 49% · Coronary heart disease 22% · Cancer 17% · Depression 12% · Diabetes 11% · Atrial fibrillation 11% · Chronic kidney disease 10% · Heart failure 8% · COPD 4% · Stroke 4%.
The office billed $439,376, Medicare allowed $156,397 and paid $124,973; for 2,148 services of 35 kinds; $38,547 of it was for drugs given in the office and $86,426 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 304 | 2,148 | 76 | 0.77 | $439,376 | $124,973 |
| 2023 | 403 | 1,891 | 75 | 0.82 | $457,317 | $141,776 |
| 2022 | 349 | 1,652 | 74 | 0.85 | $394,390 | $125,190 |
| 2021 | 286 | 1,034 | 75 | 0.81 | $307,869 | $91,039 |
| 2020 | 204 | 272 | 75 | 1.39 | $64,700 | $17,321 |
| 2019 | 409 | 1,265 | 76 | 1.13 | $296,894 | $73,851 |
| 2018 | 336 | 1,925 | 76 | 1.04 | $402,130 | $106,978 |
| 2017 | 341 | 1,577 | 76 | 0.94 | $312,953 | $88,909 |
| 2016 | 278 | 563 | 75 | 1.02 | $152,349 | $40,780 |
| 2015 | 54 | 83 | 76 | 1.04 | $22,361 | $6,535 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 268 | $45,917 | $109 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 167 | $25,539 | $153 |
| Long return visit (40+ min) | 90 | $18,885 | $156 |
| Short return visit (20+ min) | 129 | $10,913 | $76 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 21 | $5,902 | $281 |
| Influenza vaccine split virus, preservative free | 48 | $3,449 | $72 |
| Telephone medical discussion with physician, 21-30 minutes | 16 | $2,219 | $117 |
| Administration of influenza virus vaccine | 48 | $1,706 | $36 |
| Sarscov2 vac 50 mcg/0.5ml im | 11 | $1,573 | $143 |
| Adm sarscv2 bvl 50mcg/.5ml a | 20 | $968 | $48 |
| Admn sarscov2 vacc 1 dose | 17 | $822 | $48 |
| Administration of pneumococcal vaccine | 21 | $762 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $365 | $12 |
| Automated urinalysis test | 21 | $46 | $2 |
2022: 9 services
| Return visit (30+ min) | 217 | $36,831 | $111 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 153 | $23,567 | $154 |
| Long return visit (40+ min) | 70 | $18,022 | $161 |
| Short return visit (20+ min) | 136 | $11,678 | $70 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 23 | $6,396 | $278 |
| Influenza vaccine split virus, preservative free | 50 | $3,420 | $68 |
| Administration of influenza virus vaccine | 53 | $1,912 | $36 |
| Administration of pneumococcal vaccine | 29 | $1,052 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $270 | $14 |
2021: 11 services
| Return visit (30+ min) | 143 | $24,375 | $122 |
| Long return visit (40+ min) | 81 | $17,706 | $172 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $15,435 | $159 |
| Short return visit (20+ min) | 67 | $6,557 | $89 |
| New patient visit (45+ min) | 38 | $5,091 | $134 |
| Influenza vaccine split virus, preservative free | 47 | $3,063 | $65 |
| Pneumococcal vaccine, 23-valent | 23 | $2,872 | $125 |
| Administration of influenza virus vaccine | 52 | $1,103 | $21 |
| New patient visit (30+ min) | 12 | $834 | $70 |
| Administration of pneumococcal vaccine | 23 | $507 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $283 | $14 |
2020: 6 services
| Return visit (30+ min) | 38 | $4,761 | $101 |
| Return visit (30+ min) | 54 | $3,012 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,865 | $110 |
| Short return visit (20+ min) | 17 | $1,441 | $80 |
| Long return visit (40+ min) | 34 | $1,423 | $40 |
| Short return visit (20+ min) | 20 | $511 | $26 |
2019: 10 services
| Return visit (30+ min) | 240 | $31,795 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 101 | $14,103 | $140 |
| Long return visit (40+ min) | 27 | $3,954 | $120 |
| Short return visit (20+ min) | 49 | $3,620 | $64 |
| Return visit (30+ min) | 44 | $2,977 | $60 |
| Long return visit (40+ min) | 30 | $2,566 | $86 |
| Short return visit (20+ min) | 24 | $944 | $39 |
| Administration of pneumococcal vaccine | 16 | $323 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $251 | $15 |
| Automated urinalysis test | 16 | $41 | $2 |
2018: 16 services
| Return visit (30+ min) | 243 | $41,770 | $89 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 146 | $20,193 | $138 |
| Long return visit (40+ min) | 34 | $6,924 | $131 |
| Short return visit (20+ min) | 75 | $5,787 | $62 |
| Influenza vaccine split virus, preservative free | 83 | $4,433 | $52 |
| Pneumococcal vaccine, 13-valent | 19 | $3,758 | $198 |
| Pneumococcal vaccine, 23-valent | 29 | $3,062 | $106 |
| Administration of influenza virus vaccine | 85 | $2,226 | $25 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $2,139 | $194 |
| Administration of pneumococcal vaccine | 44 | $1,189 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $937 | $20 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $751 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $325 | $14 |
| Blood test, clotting time | 14 | $223 | $5 |
| Removal of impacted ear wax by washing | 15 | $191 | $13 |
| Automated urinalysis test | 28 | $84 | $3 |
2017: 15 services
| Return visit (30+ min) | 245 | $36,329 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 76 | $10,488 | $138 |
| Long return visit (40+ min) | 35 | $6,562 | $134 |
| Pneumococcal vaccine, 13-valent | 32 | $5,973 | $187 |
| Short return visit (20+ min) | 70 | $4,102 | $54 |
| Influenza vaccine split virus, preservative free | 63 | $3,027 | $48 |
| Pneumococcal vaccine, 23-valent | 25 | $2,369 | $95 |
| Administration of influenza virus vaccine | 67 | $2,157 | $32 |
| Administration of pneumococcal vaccine | 55 | $1,835 | $32 |
| New patient visit (45+ min) | 14 | $1,580 | $113 |
| New patient visit (30+ min) | 11 | $1,111 | $101 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $520 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 18 | $279 | $15 |
| Blood test, clotting time | 11 | $180 | $5 |
| Automated urinalysis test | 20 | $60 | $3 |
2016: 11 services
| Return visit (30+ min) | 186 | $21,982 | $91 |
| Short return visit (20+ min) | 88 | $4,863 | $52 |
| Pneumococcal vaccine, 13-valent | 15 | $2,623 | $175 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,357 | $139 |
| Long return visit (40+ min) | 13 | $2,171 | $128 |
| New patient visit (45+ min) | 15 | $1,863 | $124 |
| Influenza vaccine split virus, preservative free | 17 | $687 | $40 |
| Administration of pneumococcal vaccine | 17 | $610 | $32 |
| Administration of influenza virus vaccine | 17 | $546 | $32 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 21 | $331 | $16 |
| Automated urinalysis test | 33 | $102 | $3 |
2015: 2 services
| Return visit (30+ min) | 19 | $2,143 | $102 |
| Short return visit (20+ min) | 27 | $1,849 | $68 |
Drugs they prescribed that Part D paid
$116,426
Pharmacies billed $116,426 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,705 generic and fewer than 11 brand-name prescriptions · $116,426 in drug cost · 93 antibiotic prescriptions to 61 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Yuvafem | 12 | $2,888 | $241 |
| Levothyroxine | 173 | $2,460 | $14 |
| Synthroid | 24 | $1,960 | $82 |
| Escitalopram | 72 | $1,763 | $24 |
| Rosuvastatin | 76 | $1,562 | $21 |
See all 36 drugs
| Yuvafem | 12 | $2,888 | $241 |
| Levothyroxine | 173 | $2,460 | $14 |
| Synthroid | 24 | $1,960 | $82 |
| Escitalopram | 72 | $1,763 | $24 |
| Rosuvastatin | 76 | $1,562 | $21 |
| Estradiol | 17 | $1,335 | $79 |
| Gabapentin | 66 | $1,286 | $19 |
| Atorvastatin | 165 | $1,194 | $7 |
| Olmesartan Medoxomil | 45 | $1,040 | $23 |
| Omeprazole | 56 | $747 | $13 |
| Valsartan | 31 | $716 | $23 |
| Duloxetine | 18 | $657 | $36 |
| Alendronate | 83 | $562 | $7 |
| Lisinopril | 65 | $561 | $9 |
| Amitriptyline | 18 | $542 | $30 |
| Losartan | 58 | $502 | $9 |
| Amlodipine Besylate | 70 | $430 | $6 |
| Zolpidem | 33 | $358 | $11 |
| Ezetimibe | 17 | $350 | $21 |
| Trazodone | 28 | $322 | $12 |
| Albuterol Sulfate Hfa | 13 | $303 | $23 |
| Fluticasone Propionate | 15 | $283 | $19 |
| Minoxidil | 11 | $217 | $20 |
| Triamcinolone Acetonide | 14 | $152 | $11 |
| Furosemide | 18 | $147 | $8 |
| Finasteride | 11 | $139 | $13 |
| Metoprolol | 15 | $139 | $9 |
| Cephalexin | 25 | $119 | $5 |
| Pravastatin | 14 | $117 | $8 |
| Citalopram Hbr | 16 | $104 | $6 |
| Metformin Hcl Er | 15 | $64 | $4 |
| Amoxicillin-Clavulanate Potass | 11 | $61 | $6 |
| Azithromycin | 11 | $56 | $5 |
| Hydrochlorothiazide | 15 | $29 | $2 |
| Simvastatin | 15 | $19 | $1 |
| Paxlovid | 25 | $0 | $0 |
Year by year
| 2024 | 1,921 | 323 | None | None | $116,426 |
| 2023 | 2,130 | 379 | None | 11% | $134,115 |
| 2022 | 1,884 | 323 | 1% (17) | 10% | $126,343 |
| 2021 | 1,252 | 301 | 1% (14) | None | $113,883 |
| 2020 | 2,360 | 410 | 2% (48) | 16% | $219,987 |
| 2019 | 2,010 | 420 | 2% (31) | None | $163,891 |
| 2018 | 2,092 | 300 | 1% (19) | None | $156,643 |
| 2017 | 1,504 | 280 | 2% (25) | None | $104,533 |
| 2016 | 516 | 144 | 3% (13) | 15% | $41,200 |
| 2015 | 51 | 27 | None | None | $4,702 |
| 2014 | 37 | 11 | 0% (0) | None | $1,783 |
| 2013 | 12 | None | 0% (0) | None | $247 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 48 drugs
| Levothyroxine | 189 | $3,853 | $20 |
| Synthroid | 29 | $3,236 | $112 |
| Atorvastatin | 211 | $2,232 | $11 |
| Olmesartan Medoxomil | 39 | $1,922 | $49 |
| Escitalopram | 73 | $1,693 | $23 |
| Gabapentin | 67 | $1,529 | $23 |
| Rosuvastatin | 49 | $1,489 | $30 |
| Omeprazole | 75 | $1,073 | $14 |
| Estradiol | 16 | $1,070 | $67 |
| Bupropion Xl | 18 | $1,062 | $59 |
| Alendronate | 78 | $1,049 | $13 |
| Ezetimibe | 17 | $1,026 | $60 |
| Estradiol (Twice Weekly) | 11 | $840 | $76 |
| Albuterol Sulfate Hfa | 30 | $711 | $24 |
| Lisinopril | 82 | $695 | $8 |
| Methenamine Hippurate | 13 | $684 | $53 |
| Duloxetine | 15 | $659 | $44 |
| Trazodone | 37 | $601 | $16 |
| Potassium Chloride | 12 | $586 | $49 |
| Losartan | 55 | $575 | $10 |
| Fluticasone Propionate | 16 | $518 | $32 |
| Valacyclovir | 17 | $489 | $29 |
| Valsartan | 22 | $448 | $20 |
| Amlodipine Besylate | 65 | $392 | $6 |
| Paxlovid (Eua) | 37 | $370 | $10 |
| Cyclobenzaprine | 18 | $361 | $20 |
| Pantoprazole | 13 | $332 | $26 |
| Amitriptyline | 13 | $292 | $22 |
| Metoprolol | 18 | $282 | $16 |
| Triamcinolone Acetonide | 16 | $229 | $14 |
| Cephalexin | 33 | $223 | $7 |
| Metformin Hcl Er | 18 | $199 | $11 |
| Zolpidem | 24 | $168 | $7 |
| Citalopram Hbr | 19 | $149 | $8 |
| Simvastatin | 22 | $145 | $7 |
| Pravastatin | 14 | $145 | $10 |
| Dextroamphetamine-Amphetamine | 12 | $142 | $12 |
| Donepezil | 14 | $136 | $10 |
| Furosemide | 13 | $134 | $10 |
| Metformin | 14 | $127 | $9 |
| Nitrofurantoin Mono-Macro | 12 | $106 | $9 |
| Naproxen | 15 | $105 | $7 |
| Amoxicillin-Clavulanate Potass | 11 | $87 | $8 |
| Prednisone | 16 | $64 | $4 |
| Azithromycin | 13 | $60 | $5 |
| Ciprofloxacin | 13 | $50 | $4 |
| Hydrochlorothiazide | 14 | $49 | $3 |
| Lorazepam | 14 | $42 | $3 |
2022: 40 drugs
| Levothyroxine | 189 | $3,673 | $19 |
| Synthroid | 25 | $2,711 | $108 |
| Rosuvastatin | 39 | $2,313 | $59 |
| Atorvastatin | 178 | $1,963 | $11 |
| Ipratropium | 11 | $1,676 | $152 |
| Gabapentin | 71 | $1,557 | $22 |
| Duloxetine | 16 | $1,549 | $97 |
| Estradiol | 18 | $1,413 | $79 |
| Escitalopram | 62 | $1,347 | $22 |
| Alendronate | 95 | $1,102 | $12 |
| Pregabalin | 13 | $1,051 | $81 |
| Omeprazole | 51 | $951 | $19 |
| Ventolin Hfa | 12 | $799 | $67 |
| Bupropion Xl | 17 | $784 | $46 |
| Potassium Chloride | 17 | $672 | $40 |
| Olmesartan Medoxomil | 21 | $667 | $32 |
| Omega-3 Acid Ethyl Esters | 11 | $512 | $47 |
| Losartan | 51 | $487 | $10 |
| Lisinopril | 73 | $483 | $7 |
| Amlodipine Besylate | 75 | $452 | $6 |
| Amitriptyline | 18 | $393 | $22 |
| Fluticasone Propionate | 20 | $323 | $16 |
| Trazodone | 32 | $318 | $10 |
| Pantoprazole | 12 | $315 | $26 |
| Valsartan | 14 | $283 | $20 |
| Paxlovid (Eua) | 27 | $273 | $10 |
| Cyclobenzaprine | 15 | $262 | $17 |
| Metoprolol | 16 | $253 | $16 |
| Simvastatin | 26 | $209 | $8 |
| Triamcinolone Acetonide | 14 | $183 | $13 |
| Pravastatin | 13 | $172 | $13 |
| Zolpidem | 23 | $169 | $7 |
| Hydrocodone-Acetaminophen | 11 | $135 | $12 |
| Sumatriptan | 15 | $134 | $9 |
| Cephalexin | 24 | $110 | $5 |
| Citalopram Hbr | 25 | $100 | $4 |
| Hydrochlorothiazide | 21 | $71 | $3 |
| Prednisone | 13 | $61 | $5 |
| Metformin | 20 | $53 | $3 |
| Atenolol | 11 | $42 | $4 |
2021: 24 drugs
| Flovent Hfa | 17 | $6,608 | $389 |
| Levothyroxine | 120 | $2,865 | $24 |
| Rosuvastatin | 32 | $1,913 | $60 |
| Atorvastatin | 102 | $1,536 | $15 |
| Duloxetine | 15 | $972 | $65 |
| Potassium Chloride | 12 | $958 | $80 |
| Gabapentin | 37 | $926 | $25 |
| Synthroid | 11 | $870 | $79 |
| Estradiol | 12 | $854 | $71 |
| Alendronate | 43 | $729 | $17 |
| Escitalopram | 34 | $610 | $18 |
| Losartan | 37 | $499 | $13 |
| Omeprazole | 28 | $484 | $17 |
| Lisinopril | 55 | $405 | $7 |
| Trazodone | 23 | $275 | $12 |
| Amitriptyline | 11 | $255 | $23 |
| Triamcinolone Acetonide | 11 | $225 | $20 |
| Amlodipine Besylate | 24 | $184 | $8 |
| Simvastatin | 14 | $154 | $11 |
| Citalopram Hbr | 18 | $153 | $8 |
| Ramipril | 11 | $89 | $8 |
| Zolpidem | 15 | $82 | $5 |
| Hydrochlorothiazide | 15 | $80 | $5 |
| Metformin | 15 | $70 | $5 |
2020: 55 drugs
| Eliquis | 18 | $16,543 | $919 |
| Trulicity | 12 | $15,912 | $1,326 |
| Lantus Solostar | 22 | $10,459 | $475 |
| Potassium Chloride | 25 | $5,666 | $227 |
| Levothyroxine | 180 | $4,341 | $24 |
| Rosuvastatin | 50 | $2,941 | $59 |
| Atorvastatin | 158 | $2,655 | $17 |
| Gabapentin | 67 | $2,347 | $35 |
| Omeprazole | 87 | $1,880 | $22 |
| Esomeprazole Magnesium | 14 | $1,325 | $95 |
| Bupropion Xl | 11 | $1,104 | $100 |
| Duloxetine | 15 | $1,073 | $72 |
| Metoprolol | 34 | $1,031 | $30 |
| Losartan | 81 | $1,025 | $13 |
| Ezetimibe | 14 | $973 | $69 |
| Pantoprazole | 32 | $923 | $29 |
| Losartan-Hydrochlorothiazide | 12 | $862 | $72 |
| Ropinirole | 15 | $832 | $55 |
| Lisinopril | 89 | $820 | $9 |
| Solifenacin | 13 | $707 | $54 |
| Trazodone | 43 | $698 | $16 |
| Tamsulosin | 15 | $671 | $45 |
| Synthroid | 18 | $670 | $37 |
| Fluticasone Propionate | 33 | $565 | $17 |
| Venlafaxine Hcl Er | 11 | $509 | $46 |
| Pravastatin | 21 | $494 | $24 |
| Telmisartan | 12 | $481 | $40 |
| Valacyclovir | 12 | $478 | $40 |
| Alendronate | 39 | $463 | $12 |
| Amlodipine Besylate | 70 | $459 | $7 |
| Allopurinol | 18 | $458 | $25 |
| Montelukast | 17 | $434 | $26 |
| Carvedilol | 36 | $404 | $11 |
| Escitalopram | 19 | $401 | $21 |
| Famotidine | 21 | $390 | $19 |
| Metformin | 45 | $389 | $9 |
| Simvastatin | 40 | $388 | $10 |
| Metformin Hcl Er | 35 | $369 | $11 |
| Hydrocodone-Acetaminophen | 11 | $332 | $30 |
| Triamterene-Hydrochlorothiazid | 19 | $290 | $15 |
| Warfarin | 14 | $283 | $20 |
| Sertraline | 14 | $263 | $19 |
| Clopidogrel | 15 | $262 | $17 |
| Spironolactone | 25 | $250 | $10 |
| Fluoxetine | 23 | $201 | $9 |
| Metoprolol | 22 | $192 | $9 |
| Tramadol | 24 | $182 | $8 |
| Furosemide | 26 | $168 | $6 |
| Hydrochlorothiazide | 33 | $161 | $5 |
| Citalopram Hbr | 23 | $159 | $7 |
| Nortriptyline | 23 | $124 | $5 |
| Atenolol | 12 | $120 | $10 |
| Zolpidem | 17 | $99 | $6 |
| Cephalexin | 14 | $65 | $5 |
| Lorazepam | 12 | $49 | $4 |
2019: 43 drugs
| Flovent Hfa | 35 | $11,317 | $323 |
| Atorvastatin | 176 | $4,745 | $27 |
| Levothyroxine | 136 | $3,475 | $26 |
| Celecoxib | 24 | $2,815 | $117 |
| Rosuvastatin | 35 | $2,004 | $57 |
| Synthroid | 34 | $1,987 | $58 |
| Gabapentin | 64 | $1,859 | $29 |
| Esomeprazole Magnesium | 23 | $1,845 | $80 |
| Mirtazapine | 12 | $1,349 | $112 |
| Escitalopram | 36 | $1,256 | $35 |
| Losartan | 80 | $1,152 | $14 |
| Lisinopril | 94 | $1,058 | $11 |
| Alendronate | 77 | $1,049 | $14 |
| Omeprazole | 30 | $1,022 | $34 |
| Pantoprazole | 26 | $966 | $37 |
| Metoprolol | 27 | $916 | $34 |
| Valacyclovir | 16 | $883 | $55 |
| Allopurinol | 23 | $825 | $36 |
| Pravastatin | 22 | $805 | $37 |
| Bupropion Xl | 12 | $780 | $65 |
| Diclofenac | 19 | $748 | $39 |
| Simvastatin | 40 | $653 | $16 |
| Amlodipine Besylate | 56 | $605 | $11 |
| Potassium Chloride | 11 | $547 | $50 |
| Montelukast | 11 | $407 | $37 |
| Fluticasone Propionate | 30 | $347 | $12 |
| Metformin Hcl Er | 30 | $336 | $11 |
| Hydrocodone-Acetaminophen | 16 | $317 | $20 |
| Trazodone | 20 | $313 | $16 |
| Donepezil | 15 | $282 | $19 |
| Losartan-Hydrochlorothiazide | 17 | $268 | $16 |
| Triamterene-Hydrochlorothiazid | 16 | $245 | $15 |
| Ranitidine | 13 | $228 | $18 |
| Metformin | 16 | $221 | $14 |
| Zolpidem | 24 | $214 | $9 |
| Carvedilol | 12 | $200 | $17 |
| Citalopram Hbr | 12 | $166 | $14 |
| Furosemide | 29 | $159 | $5 |
| Glipizide | 15 | $141 | $9 |
| Azithromycin | 20 | $134 | $7 |
| Hydrochlorothiazide | 24 | $129 | $5 |
| Cyclobenzaprine | 14 | $97 | $7 |
| Cephalexin | 13 | $48 | $4 |
2018: 48 drugs
| Creon | 12 | $12,180 | $1,015 |
| Flovent Hfa | 22 | $7,375 | $335 |
| Atorvastatin | 193 | $6,081 | $32 |
| Advair Diskus | 12 | $6,018 | $501 |
| Levothyroxine | 150 | $3,736 | $25 |
| Esomeprazole Magnesium | 19 | $2,964 | $156 |
| Synthroid | 32 | $1,946 | $61 |
| Mirtazapine | 21 | $1,610 | $77 |
| Gabapentin | 55 | $1,360 | $25 |
| Metoprolol | 42 | $1,224 | $29 |
| Rosuvastatin | 23 | $1,217 | $53 |
| Lisinopril | 112 | $1,187 | $11 |
| Omeprazole | 36 | $1,115 | $31 |
| Alendronate | 89 | $1,088 | $12 |
| Allopurinol | 29 | $1,056 | $36 |
| Escitalopram | 41 | $1,015 | $25 |
| Fluticasone Propionate | 45 | $990 | $22 |
| Pantoprazole | 22 | $812 | $37 |
| Losartan | 81 | $751 | $9 |
| Pravastatin | 22 | $732 | $33 |
| Potassium Chloride | 14 | $650 | $46 |
| Simvastatin | 43 | $635 | $15 |
| Tamsulosin | 21 | $552 | $26 |
| Irbesartan | 16 | $541 | $34 |
| Valacyclovir | 15 | $538 | $36 |
| Bupropion Xl | 11 | $441 | $40 |
| Amlodipine Besylate | 46 | $394 | $9 |
| Metformin | 30 | $393 | $13 |
| Fluoxetine | 12 | $391 | $33 |
| Triamterene-Hydrochlorothiazid | 18 | $329 | $18 |
| Carvedilol | 19 | $286 | $15 |
| Nortriptyline | 16 | $284 | $18 |
| Losartan-Hydrochlorothiazide | 18 | $270 | $15 |
| Bupropion Hcl Sr | 15 | $270 | $18 |
| Glimepiride | 15 | $261 | $17 |
| Trazodone | 21 | $242 | $12 |
| Ramipril | 18 | $235 | $13 |
| Metformin Hcl Er | 14 | $222 | $16 |
| Sertraline | 11 | $181 | $16 |
| Benazepril | 13 | $170 | $13 |
| Cephalexin | 30 | $157 | $5 |
| Glipizide | 19 | $141 | $7 |
| Citalopram Hbr | 15 | $131 | $9 |
| Zolpidem | 17 | $130 | $8 |
| Furosemide | 17 | $121 | $7 |
| Azithromycin | 18 | $119 | $7 |
| Cyclobenzaprine | 11 | $110 | $10 |
| Hydrochlorothiazide | 23 | $79 | $3 |
2017: 32 drugs
| Esomeprazole Magnesium | 18 | $4,339 | $241 |
| Flovent Hfa | 12 | $4,231 | $353 |
| Levothyroxine | 103 | $3,006 | $29 |
| Atorvastatin | 92 | $2,235 | $24 |
| Rosuvastatin | 12 | $1,022 | $85 |
| Synthroid | 13 | $911 | $70 |
| Gabapentin | 47 | $909 | $19 |
| Metoprolol | 23 | $850 | $37 |
| Lisinopril | 80 | $785 | $10 |
| Fluticasone Propionate | 47 | $753 | $16 |
| Valacyclovir | 11 | $620 | $56 |
| Omeprazole | 30 | $617 | $21 |
| Potassium Chloride | 14 | $579 | $41 |
| Losartan | 56 | $542 | $10 |
| Pantoprazole | 21 | $484 | $23 |
| Escitalopram | 27 | $457 | $17 |
| Alendronate | 43 | $438 | $10 |
| Metformin | 40 | $402 | $10 |
| Valsartan | 11 | $378 | $34 |
| Simvastatin | 36 | $373 | $10 |
| Amlodipine Besylate | 52 | $320 | $6 |
| Venlafaxine Hcl Er | 13 | $297 | $23 |
| Triamterene-Hydrochlorothiazid | 14 | $243 | $17 |
| Trazodone | 19 | $177 | $9 |
| Azithromycin | 24 | $169 | $7 |
| Carvedilol | 12 | $139 | $12 |
| Citalopram Hbr | 17 | $128 | $8 |
| Hydrocodone-Acetaminophen | 13 | $95 | $7 |
| Hydrochlorothiazide | 17 | $82 | $5 |
| Cephalexin | 21 | $77 | $4 |
| Atenolol | 15 | $71 | $5 |
| Metoprolol | 11 | $35 | $3 |
2016: 12 drugs
| Nexium | 12 | $3,074 | $256 |
| Levothyroxine | 35 | $1,057 | $30 |
| Gabapentin | 18 | $743 | $41 |
| Fluticasone Propionate | 35 | $582 | $17 |
| Pravastatin | 14 | $369 | $26 |
| Atorvastatin | 17 | $252 | $15 |
| Nitrofurantoin Mono-Macro | 13 | $228 | $18 |
| Atenolol | 16 | $183 | $11 |
| Amlodipine Besylate | 22 | $183 | $8 |
| Azithromycin | 15 | $137 | $9 |
| Losartan | 13 | $118 | $9 |
| Cephalexin | 14 | $101 | $7 |
Money from drug and device companies
$33 in 2019
A payment is not proof that care is biased.
| Amgen | Aimovig | $33 | 1 payment
|
See the published payment
| Amgen | Meals · 2019-05-28 | Aimovig | $33 |
Professional record
- NPI
- 1093029316
- Licence
- CA A126598California A126598: Current · expires 2027-03-31
- Trained
- University of California, Davis School of Medicine, 2012 · 14 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1300 Crane Street, Menlo Park, CA, 94025
- NPI first listed
- 2010-07-28
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305